Home > Boards > Free Zone > Penny Trading - Technical > BB's Stock Haven

$PMCB ~ PharmaCyte Biotech, Inc. DD PMCB

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
$Pistol Pete$ Member Profile
Member Level 
Followed By 2,068
Posts 216,428
Boards Moderated 89
Alias Born 05/06/14
160x600 placeholder
$Pistol Pete$ Member Level  Monday, 03/20/17 06:32:12 PM
Re: None
Post # of 4256518 
$PMCB ~ PharmaCyte Biotech, Inc. DD PMCB

FDA Grants Orphan Drug Designation to Pharmacyte Biotech for Pancreatic Cancer Treatment
PharmaCyte Biotech Obtains Orphan Drug Designation in Europe for Its Pancreatic Cancer Treatment
$PMCB PharmaCyte Biotech - Diabetes Treatment Program

$PMCB Enjoy Corporate Video

$PMCB Enjoy Another Great Video YouTube TGen Leads the Way in Early Detection of Cancer. Dr. Von Hoff will lead $PMCB into FDA Fast Track Approval

$PMCB Progress Report: Pancreatic Cancer Dream Team from Dr. Von Hoff

$PMCB Watch The Cell-in-a-Box® technology, developed by Austrianova, is a means to protect, isolate, store and transport living cells.

$PMCB Meet the New SU2C Pancreatic Dream Team with Dr. Von Hoff

$PMCB Management Team and Advisors Board

$PMCB Products

$PMCB Process

$PMCB recent news/filings
$PMCB charts

$PMCB company information
## source:
Ticker: $PMCB
OTC Market Place: OTCQB
CIK code: 0001157075
Company name: PharmaCyte Biotech, Inc.
Company website: http://
Incorporated In: NV, USA
Business Description: PharmaCyte Biotech is a clinical stage biotechnology company focused on developing and preparing to commercialize treatments for cancer and diabetes based upon a proprietary cellulose-based live cell encapsulation technology known as \"Cell-in-a-Box\" This unique and patented technology will be used as a platform upon which treatments for several types of cancer, including advanced, inoperable pancreatic cancer and its symptoms, and diabetes are being developed. PharmaCyte Biotech's treatment for solid tumor cancers involves encapsulating modified live cells capable of converting the prodrug ifosfamide into its active or \"cancer-killing\" form. These encapsulated live cells are placed as close to the tumor as possible to enable the delivery of the highest levels of the cancer-killing drug at the source of the cancer. Ifosfamide is then given intravenously at one third the normal dose to eliminate adverse side effects. When the ifosfamide comes in contact with the encapsulated live cells through the circulatory system, the activation of the drug takes place at or near the tumor. This \"targeted chemotherapy\" has proven remarkably effective and safe to use in past clinical trials. PharmaCyte Biotech is also developing treatments for cancer based upon chemical constituents of the Cannabis plant. It is examining ways to exploit the benefits of Cell-in-a-Box technology in optimizing the anticancer effectiveness of Cannabis, while minimizing or outright eliminating the debilitating side effects usually associated with cancer treatments. In addition to developing treatments for pancreatic and other cancers, PharmaCyte Biotech is developing a treatment for Type 1 diabetes and Type 2 insulin-dependent diabetes. PharmaCyte Biotech plans to encapsulate a human cell line which has been genetically engineered to produce, store and secrete insulin on demand at levels in proportion to the levels of blood sugar in the human body. The encapsulation will be done using the Cell-in-a-Box technology.Less >>
$PMCB share structure
## source:
Share Structure
Market Value1 $43,985,581 a/o Jul 01, 2016
Authorized Shares 1,490,000,000 a/o Feb 22, 2016
Outstanding Shares 772,083,226 a/o Mar 08, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 529,206,849 a/o Feb 22, 2016
Par Value 0.0001
$PMCB extra dd links
Company name: PharmaCyte Biotech, Inc.
Company website: http://
After Hours Quote (
Option Chain (
Historical Prices (
Company Profile (
Industry (
Market Stream (
Latest news ( -
Analyst Research (
Guru Analysis (
Stock Report (
Competitors (
Stock Consultant (
Stock Comparison (
Investopedia (
Research Reports (
Basic Tech. Analysis (
Barchart (
Spoke company information (
Corporation WIKI (
Alexa (
Corporate website internet archive (*/http://
Call Transcripts (
Annual Report (
Income Statement (
Revenue/EPS (
SEC Filings (
Edgar filings (
Latest filings (
Latest financials (
Short Interest (
Dividend History (
RegSho (
OTC Short Report (
Short Sales (
Key Statistics (
Insider Roster (
Income Statement (
Balance Sheet (
Cash Flow (
Major holdings (
Insider transactions (
Insider transactions (
Insider transactions (
Ownership Summary (
Institutional Holdings (
Insiders (SEC Form 4) (
Insider Disclosure (
Market Watch (
Bloomberg (
Morningstar (
Bussinessweek ($Pistol-Pete$-$Mick$-&-Friends-Stock-Picks-29568/

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
Current Price
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist